Multi-Channel Communication for Improvements in Cancer Education and Outcomes (MICEO) in Underserved Populations

项目摘要 儿童癌症幸存者是HPV疫苗接种的高度优先、服务不足的人群。他们没有那么多 与普通人群相比，更有可能接种疫苗，更有可能发展为第二 成年后由人乳头瘤病毒引起的癌症。圣犹大综合癌症中心(SJCCC)的独特定位是 解决观察到的儿童癌症幸存者HPV疫苗接种覆盖率的差异 我们在我们的集水区独一无二的覆盖范围，并以屡获殊荣的最先进的通信为基础 与在SJCCC接受治疗的患者及其家人进行的系统检查。拟议的行政部门的总体目标 补充是为了提高儿童癌症幸存者的HPV疫苗接种覆盖率。具体目标是 (1)开展创新的、有文化针对性的、多渠道的教育活动，以增进健康 普及与HPV疫苗接种有关的知识，提高儿童癌症HPV疫苗接种覆盖率 幸存者；以及(2)试点测试多渠道教育活动，以了解其对知识和 目的并告知下一步行动。我们建议的计划将建立在现有和新开发的患者的基础上 家庭和面向幸存者的英语和西班牙语教育资源，这些资源是设计和 进行宣传，以促进和促进健康知识普及。我们的方法将是高度迭代的，包括 圣犹大内主要办公室的参与，包括圣公会社区推广和参与、人类免疫缺陷病毒 癌症预防计划，战略沟通，教育和外展，以患者家庭为中心 护理、患者体验办公室、过渡肿瘤学计划、完成治疗诊所后，以及MOST 重要的是，通过我们与患者家属和儿童癌症幸存者的定期互动， 患者家庭咨询委员会和额外的患者家庭顾问。多渠道宣传活动将重点放在 在基于网络的资源和社区、社交媒体平台上，我们的圣裘德移动应用程序(APP)、 传统的打印格式，电子病历提示，用于规定的患者教育，以及点对点， 耐心的家庭冠军体验。我们将以10-30岁的年龄组为目标，通过 由父母/照顾者为其做出疫苗接种决定的10-17岁儿童和18-30岁儿童区分开来 在大多数情况下，他们可以为自己做出疫苗接种决定。我们将开发和试行HPV 通过这多个渠道开展疫苗接种活动。我们的项目活动将被记录和监控 通过全面的流程评估。我们努力的初步影响也将用 定性、定量和分析数据，包括之前对HPV疫苗接种率的评估 并在运动实施期之后。我们的努力将与圣犹大的沟通和 从教育资源入手，优化可持续性。我们将公开分享我们的发现 其他癌症中心和组织为儿童癌症幸存者提供服务，并继续完善和测试我们的 确保我们通过增加儿童HPV疫苗接种覆盖率来实现影响的方法 癌症幸存者。

PROJECT ABSTRACT Childhood cancer survivors are a high-priority, underserved population for HPV vaccination. They are less likely to be vaccinated when compared to the general population and are more likely to develop second cancers caused by HPV as adults. St. Jude Comprehensive Cancer Center (SJCCC) is uniquely positioned to address observed disparities in HPV vaccination coverage among childhood cancer survivors by leveraging our unique reach across our catchment area and building on award-winning, state-of-the-art communication systems with those treated at SJCCC and their families. The overall goal of the proposed administrative supplement is to improve HPV vaccination coverage among childhood cancer survivors. The specific aims are to: (1) develop an innovative, culturally targeted, multi-channel educational campaign to enhance health literacy related to HPV vaccination and to improve HPV vaccination coverage among childhood cancer survivors; and (2) pilot test the multi-channel educational campaign to understand its impact on knowledge and intention and to inform the next steps. Our proposed plan will build on established and newly developed patient families and survivor-facing educational resources in English and Spanish, which are designed and disseminated to promote and facilitate health literacy. Our approach will be highly iterative and include engagement of key offices within St. Jude, including SJCCC Community Outreach and Engagement, HPV Cancer Prevention Program, Strategic Communication, Education and Outreach, Patient Family Centered Care, Patient Experience Office, Transition Oncology Program, After Completion of Therapy Clinic, and most importantly, through our regular interaction with patient families and childhood cancer survivors through the Patient Family Advisory Council and additional patient family advisors. The multi-channel campaign will focus on web-based resources and communities, social media platforms, Our St. Jude mobile application (app), traditional print formats, electronic medical record prompts for prescribed patient education, and peer-to-peer, patient family champion experiences. We will target the 10-30-year-old age group with approaches differentiated by 10-17-year-olds for whom parent/caregivers make vaccination decisions and 18-30-year olds who can make vaccination decisions for themselves, in most instances. We will develop and pilot test an HPV vaccination campaign across these multiple channels. Our project activities will be documented and monitored through a comprehensive process evaluation. The preliminary impact of our efforts will also be measured using qualitative, quantitative, and analytical data, including assessment of aggregated HPV vaccination rates before and after the campaign implementation period. Our efforts will be aligned with St. Jude communication and educational resources from the beginning to optimize sustainability. We will openly share our findings with other cancer centers and organizations serving childhood cancer survivors and continue to refine and test our approaches to ensure we are achieving impact through increased HPV vaccination coverage among childhood cancer survivors.